Medicare Enrolled
Dr. Brion Lock, M.D.
Pulmonary Disease · Marietta, GA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Lock from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Lock?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Lock
Dr. Brion Lock is a pulmonary disease specialist in Marietta, GA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Lock performed 8,503 Medicare services across 3,630 unique beneficiaries.
Between the years covered by Open Payments, Dr. Lock received a total of $20,703 from 47 pharmaceutical and/or device companies across 658 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in pulmonary disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Lock is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 1% volume in GA
$20,703 industry payments
Medicare Practice Summary
Medicare Utilization ↗8,503
Medicare services
Top 1% in GA for pulmonary disease
3,630
Unique beneficiaries
$65
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~425 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Injection, benralizumab, 1 mg | 1,771 | $132 | $560 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
1,362 | $136 | $496 |
| Chest X-ray, 2 views An X-ray imaging test of the chest that captures two different angles to visualize the lungs, heart, and chest wall. |
867 | $13 | $56 |
| Steroid injection (triamcinolone) A 10 mg injection of triamcinolone acetonide, a corticosteroid medication. This code specifies the drug and dosage administered. |
824 | $1 | $6 |
| Expiratory airflow and volume test A test that measures the amount of air you can exhale and the speed at which you can breathe it out. It evaluates lung function by assessing expiratory airflow and volume. |
682 | $20 | $121 |
| Lung volume test using sensors A test that measures the amount of air in the lungs using sensors. |
611 | $41 | $184 |
| Nitric oxide gas level test A test that measures the level of nitric oxide gas in the body. |
425 | $14 | $69 |
| Pulmonary gas exchange test A test to examine how well the lungs exchange gases. |
301 | $44 | $188 |
| Breathing device use evaluation An assessment of how a patient uses a breathing device. The provider reviews the patient's technique and device handling. |
288 | $12 | $58 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
214 | $11 | $69 |
| Exercise-induced lung stress test A test performed to evaluate how the lungs function during physical exertion. It helps identify breathing difficulties or lung conditions that occur specifically when exercising. |
213 | $26 | $117 |
| Spirometry test before and after medication A test that measures the amount of air you can exhale and the speed of your breathing before and after taking a medication. |
195 | $29 | $203 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
169 | $8 | $23 |
| New patient office visit, complex (60-74 min) | 93 | $173 | $705 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
85 | $95 | $355 |
| Smoking cessation counseling, more than 10 minutes Intensive counseling session focused on helping patients quit smoking and tobacco use, lasting more than 10 minutes. |
54 | $28 | $97 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
50 | $90 | $370 |
| Lung cancer screening counseling visit A visit to discuss the need for lung cancer screening using a low-dose CT scan. This service is used to determine eligibility and facilitate shared decision making. |
49 | $28 | $99 |
| Chest X-ray, 1 view An X-ray image of the chest taken from a single angle. This imaging test is used to visualize the structures within the chest cavity. |
47 | $10 | $44 |
| Flu vaccine administration This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient. |
45 | $31 | $57 |
| Flu vaccine, high-dose High-dose seasonal influenza vaccine for adults aged 65 and older. Contains four times the antigen of standard-dose flu vaccines (60 mcg per strain), split-virus formulation, preservative-free, single-dose syringe. |
43 | $72 | $219 |
| Advance care planning consultation, first 30 min A session focused on discussing and documenting future healthcare preferences and goals. This service covers the initial 30 minutes of the planning discussion. |
42 | $65 | $289 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
21 | $125 | $561 |
| Pneumonia vaccine administration This procedure involves the injection of a vaccine to protect against pneumococcal disease. It is administered by a healthcare provider. |
21 | $31 | $57 |
| Pneumococcal vaccine, 23-valent A vaccine that protects against 23 types of pneumococcal bacteria. It is used to prevent infections caused by these bacteria. |
17 | $131 | $361 |
| Inhalation treatment for airway obstruction or sputum production A treatment involving the inhalation of medication to help clear airway obstructions or reduce sputum production. |
14 | $7 | $62 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$20,703
Total received (2018-2024)
Avg $2,958/year across 7 years
Top 12% in GA for pulmonary disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
47
Companies
658
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$11,872 (57.3%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$8,773 (42.4%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$57 (0.3%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$9,307
2023
$3,767
2022
$2,234
2021
$1,897
2020
$1,412
2019
$1,475
2018
$612
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
GENZYME CORPORATION
$7,198
AstraZeneca Pharmaceuticals LP
$631
GlaxoSmithKline, LLC.
$199
Boehringer Ingelheim Pharmaceuticals, Inc.
$182
Regeneron Healthcare Solutions, Inc.
$166
Grifols USA, LLC
$161
Takeda Pharmaceuticals U.S.A., Inc.
$140
PFIZER INC.
$134
HARMONY BIOSCIENCES LLC
$120
Axsome Therapeutics, Inc.
$72
3B Medical, Inc.
$47
Harmony Biosciences Llc
$43
Mylan Specialty L.P.
$40
Vifor Pharma, Inc.
$37
Amgen Inc.
$37
Philips North America LLC
$37
Insmed, Inc.
$23
Phadia US Inc.
$22
Actelion Pharmaceuticals US, Inc.
$17
Top 3 companies account for 86.3% of 2024 payments
All-time payments by company (2018-2024) ›
GENZYME CORPORATION
$9,226
AstraZeneca Pharmaceuticals LP
$2,613
GlaxoSmithKline, LLC.
$1,955
Boehringer Ingelheim Pharmaceuticals, Inc.
$1,090
Grifols USA, LLC
$896
PFIZER INC.
$486
Insmed, Inc.
$398
Takeda Pharmaceuticals U.S.A., Inc.
$363
Octapharma USA, Inc.
$334
JAZZ PHARMACEUTICALS INC.
$321
Mylan Specialty L.P.
$312
Regeneron Healthcare Solutions, Inc.
$289
Teva Pharmaceuticals USA, Inc.
$274
Axsome Therapeutics, Inc.
$251
Pulmonx Corporation
$140
Harmony Biosciences LLC
$138
Actelion Pharmaceuticals US, Inc.
$133
Sunovion Pharmaceuticals Inc.
$131
HARMONY BIOSCIENCES LLC
$120
Amgen Inc.
$119
Mallinckrodt Hospital Products Inc.
$117
Genentech USA, Inc.
$117
United Therapeutics Corporation
$83
Mallinckrodt Enterprises LLC
$72
Mallinckrodt LLC
$65
SANOFI-AVENTIS U.S. LLC
$57
3B Medical, Inc.
$47
Covis Pharma GmBH
$46
Harmony Biosciences Llc
$43
Eisai Inc.
$43
Janssen Pharmaceuticals, Inc
$42
Merck Sharp & Dohme LLC
$38
Vifor Pharma, Inc.
$37
Philips North America LLC
$37
Philips Electronics North America Corporation
$34
Jazz Pharmaceuticals Inc.
$30
ARBOR PHARMACEUTICALS, INC.
$23
Baxter Healthcare
$23
ANI Pharmaceuticals, Inc.
$22
Paratek Pharmaceuticals, Inc.
$22
Phadia US Inc.
$22
CSL Behring
$21
Bayer Healthcare Pharmaceuticals Inc.
$20
ADMA BioManufacturing LLC
$17
Inspire Medical Systems, Inc.
$17
IDORSIA PHARMACEUTICALS US INC
$15
Inogen, Inc.
$2
Top 3 companies account for 66.6% of all-time payments
Associated products mentioned in payments ›
(5044) MCOT · (8874) inCourage · (AK6) Vest Therapy · ACTHAR · AIRSUPRA · ALVESCO · ANORO · ANORO ELLIPTA · AREXVY · Adempas · AirDuo Digihaler · Arikayce · BREO · BREO ELLIPTA · BREZTRI · BREZTRI AEROSPHERE · BROVANA · CINQAIR · CUTAQUIG · CUVITRU · DUPIXENT · Dayvigo · ELIQUIS · EVUSHELD · FARXIGA · FASENRA · GLASSIA · HYQVIA · Hillrom - Life 2000 Ventilation System · Hizentra · Horizant · INSPIRE · ImmunoCAP · InogenOne · LONHALA MAGNAIR · LUNA · NUCALA · NUZYRA · OCTAGAM · OCTAGAM IMMUNE GLOBULIN (HUMAN) · OFEV · OPSUMIT · PANZYGA · PURIFIED CORTROPHIN GEL · ProAir Digihaler · Prolastin-C · Prolastin-C Liquid · Pulmonx Endobronchial Valve EBV · QUVIVIQ · SPIRIVA RESPIMAT · STIOLTO RESPIMAT · SUNOSI · SYMBICORT · Sunosi · TEZSPIRE · TRELEGY ELLIPTA · TYVASO · UPTRAVI · Utibron · WAKIX · Wakix · XARELTO · XYWAV · Xembify · Xolair · YUPELRI · Yupelri · Zemaira
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (57%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Pulmonary diseases within 10 mi
125
Per 100K population
16.3
County median income
$98,712
Nearest hospital
WELLSTAR KENNESTONE REGIONAL MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Lock is a clinical cardiology specialist, with above-average Medicare volume (top 1% in GA), with low-engagement industry engagement in the top 12% of GA peers, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Lock experienced with injection, benralizumab, 1 mg?
Based on Medicare claims data, Dr. Lock performed 1,771 injection, benralizumab, 1 mg services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Lock receive payments from pharmaceutical companies?
Yes. Dr. Lock received a total of $20,703 from 47 companies across 658 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Lock's costs compare to other pulmonary diseases in Marietta?
Dr. Lock's average Medicare payment per service is $65. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Lock) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Pulmonary Disease
Common procedures, typical costs, and what industry payments mean in pulmonary disease.
Same specialty & city
Pulmonary Diseases in Marietta
Browse pulmonary diseases in Marietta ranked by procedure volume and transparency data.
Highest volume
Top Pulmonary Diseases in GA
Pulmonary diseases ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Pulmonary Diseases in GA
Which GA pulmonary diseases receive the most from drug and device companies.
By company
GENZYME CORPORATION Payments to Doctors
See all physicians who received payments from GENZYME CORPORATION.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
GlaxoSmithKline, LLC. Payments to Doctors
See all physicians who received payments from GlaxoSmithKline, LLC.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology